Structures by: Kahlenberg V.
Total: 275
(succinic acid).(nicotinic acid hydrazide)2
2(C6H7N3O),C4H6O4
CrystEngComm (2011) 13, 1 55
a=8.0830(4)Å b=26.5860(10)Å c=8.0970(4)Å
α=90° β=104.449(4)° γ=90°
(adipic acid).(nicotinic acid hydrazide)2
C6H10O4,2(C6H7N3O)
CrystEngComm (2011) 13, 1 55
a=13.1910(8)Å b=10.3449(5)Å c=7.4635(4)Å
α=90° β=102.230(6)° γ=90°
(adipic acid).((N'-(propan-2-ylidene)nicotinohydrazide)2
C9H11N3O,0.5(C6H10O4)
CrystEngComm (2011) 13, 1 55
a=5.0880(2)Å b=38.9970(16)Å c=6.3470(2)Å
α=90° β=94.128(4)° γ=90°
(sebacic acid).(N'-(propan-2-ylidene)nicotinohydrazide)2
C10H18O4,2(C9H11N3O)
CrystEngComm (2011) 13, 1 55
a=5.07070(10)Å b=44.5556(8)Å c=6.39920(10)Å
α=90° β=94.587(2)° γ=90°
Pentobarbital, nembutal
C11H18N2O3
CrystEngComm (2012) 14, 7 2494
a=11.7361(6)Å b=11.1568(9)Å c=10.1886(6)Å
α=90.00° β=110.205(6)° γ=90.00°
Pentobarbital, nembutal
C11H18N2O3
CrystEngComm (2012) 14, 7 2494
a=16.7545(15)Å b=9.8660(8)Å c=7.1799(5)Å
α=90.00° β=90.00° γ=90.00°
Co-crystal phenobarbital + nembutal
(C12H12N2O3),(C11H18N2O3)
CrystEngComm (2012) 14, 7 2494
a=12.6733(11)Å b=20.6887(19)Å c=10.2529(7)Å
α=90.00° β=118.458(9)° γ=90.00°
Pentobarbital, nembutal
C11H18N2O3
CrystEngComm (2012) 14, 7 2494
a=14.5136(10)Å b=6.8344(3)Å c=12.4979(6)Å
α=90.00° β=104.762(6)° γ=90.00°
Nembutal, pentobarbital
C11H18N2O3
CrystEngComm (2012) 14, 7 2494
a=11.8675(10)Å b=21.824(3)Å c=10.2201(9)Å
α=90.00° β=110.476(9)° γ=90.00°
(N'-(cyclopentylidene)isonicotinohydrazide) .(3-hydroxybenzoic acid)
C11H13N3O,C7H6O3
CrystEngComm (2011) 13, 19 5692
a=19.7268(4)Å b=8.3772(2)Å c=10.1372(2)Å
α=90° β=98.644(2)° γ=90°
(N'-(cyclooctylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid)
C14H19N3O,C7H6O3
CrystEngComm (2011) 13, 19 5692
a=21.3902(15)Å b=7.8621(5)Å c=11.2995(7)Å
α=90° β=97.986(3)° γ=90°
Bis(N'-(diphenylmethylene)isonicotinohydrazide) . (3-hydroxybenzoic acid)
2(C19H15N3O),C7H6O3
CrystEngComm (2011) 13, 19 5692
a=9.8338(9)Å b=10.2475(9)Å c=10.8863(10)Å
α=104.295(8)° β=112.784(8)° γ=103.370(8)°
(N'-(propan-2-ylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C9H11N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3511(6)Å b=10.5853(8)Å c=12.8026(12)Å
α=75.694(7)° β=78.613(8)° γ=81.087(7)°
(N'-(butan-2-ylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C10H13N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3699(2)Å b=10.9498(3)Å c=12.8120(3)Å
α=81.0090(10)° β=80.5660(10)° γ=83.8590(10)°
(N'-(cycloheptylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C13H17N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3127(4)Å b=11.4293(6)Å c=26.1598(15)Å
α=90° β=91.109(5)° γ=90°
(N'-(4-methylbenzylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C14H13N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.1506(5)Å b=10.5426(6)Å c=16.2041(12)Å
α=73.603(6)° β=90.403(6)° γ=79.320(6)°
Mg ((U O2) (Se O4)2 (H2 O)) (H2 O)4
H10MgO15Se2U
Zeitschrift fuer Naturforschung, Teil B. Anorganische Chemie, Organische Chemie (42,1987-) (2005) 60, 538-542
a=8.4666Å b=11.6306Å c=13.1669Å
α=90° β=90.959° γ=90°
Zn ((U O2) (Se O4)2 (H2 O)) (H2 O)4
H10O15Se2UZn
Zeitschrift fuer Naturforschung, Teil B. Anorganische Chemie, Organische Chemie (42,1987-) (2005) 60, 538-542
a=8.4492Å b=11.586Å c=13.24Å
α=90° β=92.382° γ=90°
(N'-(1-p-tolylethylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid)
C15H15N3O,C7H6O3
CrystEngComm (2011) 13, 19 5692
a=24.4670(16)Å b=7.3712(5)Å c=10.8211(6)Å
α=90° β=99.666(6)° γ=90°
(N'-(cyclohexylidene)isonicotinohydrazide) . (3-hydroxybenzoic acid) . (H2O)
C12H15N3O,C7H6O3,H2O
CrystEngComm (2011) 13, 19 5692
a=6.3632(6)Å b=10.8918(10)Å c=13.3842(12)Å
α=87.434(7)° β=80.241(8)° γ=83.083(8)°
4-aminoquinaldine form I
C10H10N2
CrystEngComm / RSC (2015) 17, 12 2504-2516
a=5.2162(4)Å b=12.3693(9)Å c=13.1192(9)Å
α=90° β=99.065(3)° γ=90°
4-aminoquinaldine form II
C10H10N2,C0.08Cl0.33
CrystEngComm / RSC (2015) 17, 12 2504-2516
a=28.4074(8)Å b=28.4074(8)Å c=11.9126(5)Å
α=90° β=90° γ=120°
(malonic acid).(isonicotinic acid hydrazide)2
2(C6H7N3O),C3H4O4
CrystEngComm (2010) 12, 10 2856
a=7.7489(15)Å b=28.027(6)Å c=3.8702(8)Å
α=90° β=90° γ=90°
(glutaric acid).(isonicotinic acid hydrazide)
C6H7N3O,C5H8O4
CrystEngComm (2010) 12, 10 2856
a=5.0641(5)Å b=8.1495(10)Å c=16.3114(17)Å
α=76.668(10)° β=81.845(8)° γ=73.046(10)°
(adipic acid).(isonicotinic acid hydrazide)2
C6H10O4,2(C6H7N3O)
CrystEngComm (2010) 12, 10 2856
a=6.3361(4)Å b=3.8795(2)Å c=39.723(2)Å
α=90° β=90.122(5)° γ=90°
(succinic acid).(isonicotinic acid hydrazide)2
C6H7N3O,0.5(C4H6O4)
CrystEngComm (2010) 12, 10 2856
a=6.9976(4)Å b=19.5601(10)Å c=7.1495(5)Å
α=90° β=114.892(8)° γ=90°
(2,4-dihydroxybenzoic acid).(isonicotinic acid hydrazide)
C6H7N3O,C7H6O4
CrystEngComm (2010) 12, 10 2856
a=8.1931(4)Å b=5.0698(2)Å c=30.2815(13)Å
α=90° β=94.923(4)° γ=90°
(pimelic acid).(isonicotinic acid hydrazide)
C7H12O4,C6H7N3O
CrystEngComm (2010) 12, 10 2856
a=5.1055(5)Å b=7.4175(6)Å c=19.3653(15)Å
α=94.328(6)° β=93.120(6)° γ=103.660(7)°
(3-hydroxybenzoic acid).((Z)-N'-(butan-2- ylidene)isonicotinohydrazide)
C10H13N3O,C7H6O3
CrystEngComm (2010) 12, 10 2856
a=19.8053(8)Å b=8.4686(4)Å c=10.0248(4)Å
α=90° β=99.567(4)° γ=90°
(3-hydroxybenzoic acid).(N'-(propan-2- ylidene)isonicotinohydrazide)
C9H11N3O,C7H6O3
CrystEngComm (2010) 12, 10 2856
a=8.6520(3)Å b=20.8180(8)Å c=8.7850(4)Å
α=90° β=101.679(4)° γ=90°
C6H13N2,CH3N5,CH2N5
C6H13N2,CH3N5,CH2N5
Crystals (2012) 2, 1 96-104
a=8.7982(6)Å b=8.8927(7)Å c=9.7756(5)Å
α=67.827(6)° β=86.181(5)° γ=71.794(7)°
C8H8Br3N2,F6P
C8H8Br3N2,F6P
Crystals (2012) 2, 3 1017-1033
a=8.2368(5)Å b=13.4522(8)Å c=13.6605(6)Å
α=92.476(4)° β=100.965(4)° γ=92.884(5)°
Al9.12Ca5.98Fe30.7Mg5.34O72Si0.86
Al9.12Ca5.98Fe30.7Mg5.34O72Si0.86
Acta Crystallographica Section B (2019) 75, 6
a=10.3279(2)Å b=10.4340(2)Å c=14.3794(2)Å
α=93.4888(12)° β=107.3209(14)° γ=109.6626(14)°
Al18.241Ca11.96Fe61.4Mg10.68O144Si1.72
Al18.241Ca11.96Fe61.4Mg10.68O144Si1.72
Acta Crystallographica Section B (2019) 75, 6
a=10.3277(2)Å b=27.0134(4)Å c=10.4344(2)Å
α=90° β=109.668(2)° γ=90°
Bi2O11Ti4
Bi2O11Ti4
Acta Crystallographica Section B (1995) 51, 1 11-18
a=14.5999(6)Å b=3.8063(2)Å c=14.9418(8)Å
α=90° β=93.129(4)° γ=90°
Bi2O11Ti4
Bi2O11Ti4
Acta Crystallographica Section B (1995) 51, 1 11-18
a=14.6412(12)Å b=3.8032(3)Å c=10.7824(6)Å
α=90° β=136.135(5)° γ=90°
?
FK2O6ScSi2
Acta Crystallographica Section B (2016) 72, 2 209-222
a=8.9780(2)Å b=8.9780(2)Å c=8.2608(3)Å
α=90° β=90° γ=90°
?
FK2O6ScSi2
Acta Crystallographica Section B (2016) 72, 2 209-222
a=8.9939(5)Å b=8.9939(5)Å c=8.2758(7)Å
α=90° β=90° γ=90°
?
FK2O6ScSi2
Acta Crystallographica Section B (2016) 72, 2 209-222
a=8.98780(10)Å b=8.98780(10)Å c=8.2694(2)Å
α=90° β=90° γ=90°
?
FK2O6ScSi2
Acta Crystallographica Section B (2016) 72, 2 209-222
a=8.98780(10)Å b=8.98780(10)Å c=8.2694(2)Å
α=90° β=90° γ=90°
?
FK2O6ScSi2
Acta Crystallographica Section B (2016) 72, 2 209-222
a=8.9705(4)Å b=8.9705(4)Å c=8.2615(4)Å
α=90° β=90° γ=90°
?
FK2O6ScSi2
Acta Crystallographica Section B (2016) 72, 2 209-222
a=8.9622(4)Å b=8.9622(4)Å c=8.2705(4)Å
α=90° β=90° γ=90°
?
Cs3O15ScSi6
Acta Crystallographica Section B (2016) 72, 1 109-116
a=13.8611(13)Å b=13.8611(13)Å c=6.9924(10)Å
α=90.0° β=90.0° γ=120.0°
Sodium trisilicate
Na2O7Si3
Acta Crystallographica Section B (2006) 62, 3 440-446
a=20.416(6)Å b=6.4987(15)Å c=4.9294(19)Å
α=90° β=90.26(3)° γ=90°
Bariummetagermanate
Ge3O9,3(Ba)
Acta Crystallographica Section B (2006) 62, 6 1002-1009
a=13.18949(15)Å b=7.62045(5)Å c=11.71698(9)Å
α=90.00000° β=112.2783(7)° γ=90.00000°
Al2Ca2O5
Al2Ca2O5
Acta Crystallographica Section B (2008) 64, 4 417-425
a=5.2699(5)Å b=14.6984(15)Å c=5.4196(5)Å
α=90.00° β=90.00° γ=90.00°
?
Ga6O19Sr10
Acta Crystallographica Section B (2009) 65, 5 587-592
a=34.9145(13)Å b=7.9369(2)Å c=15.9150(7)Å
α=90° β=103.551(3)° γ=90°
?
Ga6O19Sr10
Acta Crystallographica Section B (2009) 65, 5 587-592
a=35.0481(18)Å b=7.9732(4)Å c=16.0077(8)Å
α=90° β=103.4920(10)° γ=90°
Febuxostat ethanol monosolvate
C16H16N2O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 6 816-819
a=4.7274(2)Å b=17.7820(5)Å c=10.7340(4)Å
α=90° β=98.994(4)° γ=90°
1,3-Dimethoxy-2-(methylsulfanyl)imidazolium tetrafluoridoborate
C6H11N2O2S,BF4
Acta Crystallographica Section E (2020) 76, 4 552-556
a=8.1049(7)Å b=11.6979(10)Å c=12.0810(12)Å
α=90° β=90.069(9)° γ=90°
1-[2-(Diethylazaniumyl)ethyl]-3-methylimidazolium tetrachloridocuprate(II)
C10H21N32,Cl4Cu2
Acta Crystallographica Section E (2015) 71, 5 m110-m111
a=17.0041(8)Å b=7.1161(6)Å c=14.4143(7)Å
α=90° β=112.956(6)° γ=90°
3-Bromo-2-hydroxybenzoic acid
C7H5BrO3
Acta Crystallographica Section E (2015) 71, 5 531-535
a=3.7978(4)Å b=10.5567(6)Å c=18.0366(10)Å
α=90° β=90.208(7)° γ=90°
2-Bromo-1,3-dimethylimidazolium iodide hemi(diiodide)
2(C5H8BrN2),2(I),I2
Acta Crystallographica Section E (2018) 74, 4 497-501
a=6.0861(4)Å b=14.4773(11)Å c=12.0303(7)Å
α=90° β=97.812(5)° γ=90°
2-Bromo-1,3-dimethylimidazolium iodide chloroform 0.33-solvate
C5H8BrN2,I,0.33333(CHCl3)
Acta Crystallographica Section E (2018) 74, 4 497-501
a=13.9135(14)Å b=21.9492(10)Å c=6.4529(6)Å
α=90° β=128.314(16)° γ=90°
2-Bromo-1,3-dimethylimidazolium iodide dichloromethane hemisolvate
2(C5H8BrN2),2(I),CH2Cl2
Acta Crystallographica Section E (2018) 74, 4 497-501
a=16.0223(8)Å b=8.5334(4)Å c=16.2881(8)Å
α=90° β=101.5900(10)° γ=90°
Idelalisib t-BuOH monosolvate dihydrate
C22H18FN7O,C4H10O,2(H2O)
Acta Crystallographica Section E (2019) 75, 3 414-417
a=21.3758(6)Å b=9.2781(3)Å c=13.9722(5)Å
α=90° β=102.654(3)° γ=90°
Bis(1,3-dimethoxyimidazolin-2-ylidene)silver(I) hexafluoridophosphate
C10H16AgN4O4,F6P
Acta Crystallographica Section E (2015) 71, 12 m251-m252
a=7.5254(7)Å b=11.7221(12)Å c=11.8697(12)Å
α=109.481(9)° β=100.698(8)° γ=100.052(8)°
Nickel zinc oxide
ONi0.9Zn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=4.18564(4)Å b=4.18564(4)Å c=4.18564(4)Å
α=90.00000° β=90.00000° γ=90.00000°
Nickel zinc oxide
ONi0.9Zn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=4.18455(2)Å b=4.18455(2)Å c=4.18455(2)Å
α=90.00000° β=90.00000° γ=90.00000°
Nickel zinc oxide
ONi0.9Zn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=2.95403(7)Å b=2.95403(7)Å c=7.2801(4)Å
α=90.00000° β=90.00000° γ=120.00000°
Nickel zinc oxide
ONi0.9Zn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=2.95546(5)Å b=2.95546(5)Å c=7.2665(3)Å
α=90.00000° β=90.00000° γ=120.00000°
Nickel zinc oxide
ONi0.9Zn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=2.95557(9)Å b=2.95557(9)Å c=7.2626(5)Å
α=90.00000° β=90.00000° γ=120.00000°
Nickel zinc oxide
ONi0.9Zn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=2.96064(5)Å b=2.96064(5)Å c=7.2592(3)Å
α=90.00000° β=90.00000° γ=120.00000°
Ni0.9OZn0.1
Ni0.9OZn0.1
Journal of Applied Crystallography (2010) 43, 4 699-709
a=2.96070(1)Å b=2.96070(1)Å c=7.25817(7)Å
α=90.00000° β=90.00000° γ=120.00000°
?
Fe2NiO4
Journal of Applied Crystallography (2010) 43, 4 699-709
a=8.35966(16)Å b=8.35966(16)Å c=8.35966(16)Å
α=90.00000° β=90.00000° γ=90.00000°
(<i>E</i>)-2,6-Dibromo-4-{2-[1-(1<i>H</i>,1<i>H</i>,2<i>H</i>,2<i>H</i>-perfluorooctyl)pyridinium-4-yl]ethenyl}phenolate methanol disolvate
C21H12Br2F13NO,2(CH4O)
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1526-1529
a=22.2362(7)Å b=6.7922(18)Å c=18.9098(5)Å
α=90° β=103.989(3)° γ=90°
I>cis</i>-Diamminebis(nitrito-κ<i>N</i>)platinum(II)
H6N4O4Pt
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 4 366-370
a=6.8656(5)Å b=12.6428(8)Å c=7.0931(5)Å
α=90° β=110.579(8)° γ=90°
Alogliptin
C18H21N5O2
Acta Crystallographica Section C (2013) 69, 6 674-678
a=8.4528(5)Å b=8.5689(5)Å c=12.4424(7)Å
α=87.840(5)° β=72.284(5)° γ=87.368(8)°
Alogliptin benzoate
C18H22N5O2,C7H5O2
Acta Crystallographica Section C (2013) 69, 6 674-678
a=8.0666(2)Å b=9.8727(2)Å c=28.4593(6)Å
α=90° β=90° γ=90°
Telaprevir
C36H53N7O6
Acta Crystallographica Section C (2013) 69, 2 179-182
a=10.4235(2)Å b=19.1651(2)Å c=37.2907(4)Å
α=90.00° β=90.00° γ=90.00°
Codeine hydrogen dihydrogen phosphate hemihydrate
C18H22NO3,H2O4P,0.5H2O
Acta Crystallographica Section C (2009) 65, 8 o419-o422
a=6.9113(2)Å b=33.4470(9)Å c=8.0716(2)Å
α=90.00° β=99.778(3)° γ=90.00°
Europium(III) scandate(III)
Eu0.968O2.952Sc
Acta Crystallographica Section E (2009) 65, 2 i8
a=5.7554(7)Å b=7.9487(10)Å c=5.5087(6)Å
α=90° β=90° γ=90°
Terbium(III) scandate(III)
O2.94ScTb0.96
Acta Crystallographica Section E (2008) 64, 11 i79
a=5.7233(8)Å b=7.9147(12)Å c=5.4543(7)Å
α=90° β=90° γ=90°
Dipotassium hydrogen carbonate fluoride monohydrate
2(K),HCO3,F,H2O
Acta Crystallographica Section E (2013) 69, 4 i20
a=5.4228(4)Å b=7.1572(6)Å c=7.4539(7)Å
α=90° β=105.121(9)° γ=90°
Nonapotassium triyttrium dodecasilicate difluoride
F2K9O32Si12Y3
Acta Crystallographica Section E (2014) 70, 2 i11
a=6.8187(3)Å b=11.3345(4)Å c=11.3727(5)Å
α=87.846(3)° β=89.747(4)° γ=80.524(3)°
Adipic acid--nicotinohydrazide (1/2)
2(C6H7N3O),C6H10O4
Acta Crystallographica Section E (2012) 68, 1 o190
a=15.9747(4)Å b=7.3309(2)Å c=8.7451(2)Å
α=90° β=103.729(3)° γ=90°
Dithulium disilicate
O7Si2Tm2
Acta Crystallographica Section E (2014) 70, 7 i34-i35
a=6.8205(14)Å b=8.9062(18)Å c=4.6937(11)Å
α=90° β=101.78(2)° γ=90°
<i>N</i>'-Cyclododecylidenepyridine-4-carbohydrazide
C18H27N3O
Acta Crystallographica Section E (2012) 68, 4 o1205
a=14.8450(6)Å b=8.0980(4)Å c=27.3910(11)Å
α=90° β=90° γ=90°
<i>N</i>'-Cyclopentylidenepyridine-4-carbohydrazide
C11H13N3O
Acta Crystallographica Section E (2012) 68, 5 o1299
a=15.762(3)Å b=8.1144(16)Å c=16.015(3)Å
α=90° β=90° γ=90°
Dirubidium lutetium tetrasilicate fluoride
FLuO10Rb2Si4
Acta Crystallographica Section E (2014) 70, 3 i14
a=11.6695(3)Å b=8.52379(18)Å c=11.8165(3)Å
α=90° β=111.753(3)° γ=90°
4-Amino-1-benzyl-1,2,4-triazolin-5-one
C9H10N4O
Acta Crystallographica Section E (2014) 70, 10 o1083-o1084
a=18.0861(8)Å b=4.1690(2)Å c=12.3694(6)Å
α=90° β=104.003(5)° γ=90°
Ca4K2O21Si8
Ca4K2O21Si8
Inorganic Chemistry (2009) 48, 11929-11934
a=6.8052(3)Å b=7.1049(3)Å c=11.2132(5)Å
α=96.680(4)° β=105.280(4)° γ=109.259(4)°
Beta resoryclic acid form I
C7H6O4
Crystal growth & design (2011) 11, 1 210-220
a=23.1978(4)Å b=5.5469(1)Å c=5.1980(1)Å
α=90° β=92.215(1)° γ=90°
Beta resoryclic acid hemihydrate
2(C7H6O4),H2O
Crystal growth & design (2011) 11, 1 210-220
a=7.0270(4)Å b=9.5449(4)Å c=11.1763(5)Å
α=96.684(4)° β=104.319(5)° γ=98.903(4)°
Beta resoryclic DMSO hemisolvate
2(C7H6O4),C2H6OS
Crystal growth & design (2011) 11, 1 210-220
a=6.39832(12)Å b=11.7099(3)Å c=23.2362(5)Å
α=90° β=90° γ=90°
Beta resoryclate pyridinium salt
C7H5O4,C5H6N
Crystal growth & design (2011) 11, 1 210-220
a=11.7363(4)Å b=8.5691(2)Å c=11.8310(4)Å
α=90° β=115.973(5)° γ=90°
4-amino-1,2,4-triazole hydrochloride
C2H5ClN4
Crystal Growth & Design (2006) 6, 2 404
a=7.1584(14)Å b=8.1640(16)Å c=9.3954(19)Å
α=90.00° β=102.97(3)° γ=90.00°
1-aminoimidazole hydrochloride
C3H6ClN3
Crystal Growth & Design (2006) 6, 2 404
a=9.3559(19)Å b=4.9432(10)Å c=12.182(2)Å
α=90.00° β=97.76(3)° γ=90.00°
1-amino-1,2,4-triazole hydrochloride
C2H5ClN4
Crystal Growth & Design (2006) 6, 2 404
a=5.0990(10)Å b=7.2298(14)Å c=15.042(3)Å
α=90.00° β=96.52(3)° γ=90.00°
1,3-diamino-1,2,3-triazolium chloride
C2H6ClN5
Crystal Growth & Design (2006) 6, 2 404
a=5.5395(12)Å b=13.402(3)Å c=7.7150(10)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
1,4-diamino-1,2,4-triazolium chloride
C2H6ClN5
Crystal Growth & Design (2006) 6, 2 404
a=5.6109(5)Å b=6.7780(9)Å c=16.3497(5)Å
α=90.00° β=90.00° γ=90.00°
1-amino-1,2,3-triazole hydrochloride
C2H5ClN4
Crystal Growth & Design (2006) 6, 2 404
a=5.0579(3)Å b=7.0018(3)Å c=7.6470(5)Å
α=90.00° β=91.716(3)° γ=90.00°
C9H17N2,CNS
C9H17N2,CNS
Crystal Growth & Design (2012) 12, 4 1838
a=10.5732(11)Å b=13.739(2)Å c=16.5878(18)Å
α=90.000° β=90.000° γ=90.000°
C9H17N2,C3HO2
C9H17N2,C3HO2
Crystal Growth & Design (2012) 12, 4 1838
a=7.1066(15)Å b=20.285(3)Å c=9.274(2)Å
α=90.000° β=110.168(16)° γ=90.000°
C9H17N2,Cl9Ti2
C9H17N2,Cl9Ti2
Crystal Growth & Design (2012) 12, 4 1838
a=8.8562(5)Å b=9.4412(4)Å c=13.3806(6)Å
α=75.251(3)° β=86.185(3)° γ=86.496(3)°
2(C9H17N2),CeCl6
2(C9H17N2),CeCl6
Crystal Growth & Design (2012) 12, 4 1838
a=10.071(5)Å b=15.568(5)Å c=17.737(5)Å
α=90.000° β=92.127(5)° γ=90.000°
C9H17N2,CClCuN
C9H17N2,CClCuN
Crystal Growth & Design (2012) 12, 4 1838
a=9.1026(9)Å b=13.6901(17)Å c=20.269(2)Å
α=90.000° β=90.000° γ=90.000°
C9H17N2,C0.33Cl0.67N0.33
C9H17N2,C0.33Cl0.67N0.33
Crystal Growth & Design (2012) 12, 4 1838
a=28.3294(3)Å b=28.3294(8)Å c=7.2009(5)Å
α=90.00° β=90.00° γ=120.00°
C9H17N2,Cl0.30,N2.10
C9H17N2,Cl0.30,N2.10
Crystal Growth & Design (2012) 12, 4 1838
a=28.2470(10)Å b=28.247(2)Å c=7.301(2)Å
α=90.00° β=90.00° γ=120.00°